First Series 2006 - Conferencias del XII Congreso SOLACI 2006 en Porto Alegre, Brasil

Stenting carotídeo: ¿Quiénes son los candidatos hoy? Dr. Giancarlo Biamino

solaci
solaci
478
0

Stenting carotídeo: ¿Quiénes son los candidatos hoy? Dr. Giancarlo Biamino

Previous article
Ampliando los horizontes del intervenc ionismo en la terapia vascular: Visión futura Dr. Martín León
Next article
Enfermedad carotídea Dr. Costantino Pena
solaci
solaci

More articles by this author

Conferencia del Dr. Qureshi

solaci - 0
Conferencia del Dr. Qureshi

Stent Thrombosis: a note of caution Dr. Conrad Simpfendorfer

solaci - 0
Stent Thrombosis: a note of caution Dr. Conrad Simpfendorfer

Dosis de clopidogrel: ¿300 mg, 600 mg, 900 mg, o más? Dr. Neil Kleiman

solaci - 0
Dosis de clopidogrel: ¿300 mg, 600 mg, 900 mg, o más? Dr. Neil Kleiman

Angioplastia para Oclusión Total Crónica Dr. Shigeru Saito

solaci - 0
Angioplastia para Oclusión Total Crónica Dr. Shigeru Saito

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Dr. Juan Manuel Pérez - 0
Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 0
Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 0
Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...